A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer.
Clinical trial NCT06018116 · WITHDRAWN
Trial details
- NCT number
- NCT06018116
- Sponsor
- CHU de Quebec-Universite Laval
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2024-01-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.